Fintel reports that on May 27, 2025, HC Wainwright & Co. downgraded their outlook for Unity Biotechnology (NasdaqGS:UBX) from ...

PDS Biotechnology (NASDAQ:PDSB) filed to sell 9.82M shares of common stock for holders. This preliminary prospectus is not an offer to sell. Filing More on PDS Biotechnology PDS Biotech outlines ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...

MAIA Biotechnology, Inc.’s MAIA share price has surged by 11.93%, which has investors questioning if this is right time to sell.

Vir Biotechnology, Inc. (NASDAQ:VIR) has already been able to initiate its late-stage ECLIPSE program, which is using the combination of monoclonal antibody tobevibart in combination with small ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

One company value investors might notice is Puma Biotechnology (PBYI). PBYI is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. PBYI is also sporting a PEG ratio of 1.38.

This fund holds a portfolio of 75-125 biotechnology stocks, balanced between established large-cap names and smaller companies with more growth potential but also more risk. The managers aim to ...

Too often, when people think of biotechnology and warfare, they remember headline-generating stories about biotechnology's misuse in the creation of new weapons of mass destruction. But lost among ...